MASCC Risk Index

Febrile neutropenia — identifies low-risk patients (score ≥ 21), maximum 26
Burden of febrile neutropenia
No hypotension (systolic BP > 90 mmHg)
No chronic obstructive pulmonary disease
Solid tumour, or haematological malignancy with no previous fungal infection
No dehydration requiring parenteral fluids
Outpatient at onset of fever
Age < 60 years
Select the burden of illness

About this score

When to use

Identifies cancer patients with febrile neutropenia at low risk of serious complications; a score of 21 or more marks low risk. ⁦[1]⁩

Pearls and pitfalls

A score of 21 or more had a positive predictive value of about 91% for low risk, with 71% sensitivity and 68% specificity. ⁦[1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Klastersky J, Paesmans M, Rubenstein EB, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. A score ≥ 21 predicted low risk of serious complications with a positive predictive value of ~91%, sensitivity 71% and specificity 68%.
Journal of Clinical Oncology, 2000
Open source
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore